M3 Advisory Group’s Merck MRK Stock Holding History

M3 Advisory Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$265K	Buy	2,203 +229	+12%	+$26.4K	0.16%	109
2025 Q4	$208K	Buy	+1,974	New	+$185K	0.13%	135

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

M3 Advisory Group's MRK Position: Q1 2026 in Review

M3 Advisory Group increased its Merck (MRK) stake by 12% in Q1 2026, buying an estimated $26.4K and bringing the position to 2,203 shares worth $265K. The position accounts for 0.16% of the portfolio, ranked #109.

M3 Advisory Group first reported a position in MRK in Q4 2025 and has held it in 2 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

M3 Advisory Group held 2,203 shares of Merck worth $265K as of Q1 2026.
M3 Advisory Group bought 229 Merck shares in Q1 2026, an estimated $26.4K.
Merck made up 0.16% of M3 Advisory Group's portfolio in Q1 2026, its #109 holding.
M3 Advisory Group first reported a position in Merck in Q4 2025 and has held it in 2 quarters since.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on M3 Advisory Group's 13F filing for Q1 2026, filed 22 Apr 2026.